Oxford Biomedica plc announced a change to the Group's Board of Directors. Dr. Siyamak ("Sam") Rasty has informed the Board that he will not be standing for re-election at the Company's AGM in June 2023. Sam joined the Board in December 2020 and is a member of the Scientific and Technology Advisory Committee and was a member of the Audit Committee until December 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
328 GBX | +9.33% | +43.54% | +49.09% |
May. 03 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
Apr. 29 | FTSE 100 as investors look to Fed rate decision | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.09% | 412M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford Biomedica plc Announces Siyamak Rasty Will Not Be Standing for Re-Election